BIOCRYST PHARMACEUTICALS, INC.

Calendar BioCryst Pharmaceuticals, Inc.

Stocks

BCRX

US09058V1035

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 11:45:22 2026-07-24 EDT			5-day change	1st Jan Change
9.395 ^USD	+0.16%		+0.81%	+20.06%

07-15	BioCryst Pharmaceuticals, Inc. Announces Appointment of David W. Jenkins as Chief Scientific Officer, Effective July 15, 2026	CI
07-07	RBC Capital Adjusts BioCryst Pharmaceuticals Price Target to $14 From $13, Maintains Outperform Rating	MT

Chart calendar BioCryst Pharmaceuticals, Inc.

4a992612bdad1.zPjmYNEKkvpKZnM7Pthi2y-1WI26mbcU2f2XHRoL_Og._sqALplup6oFUiR_fIky6mn-E_zK6v5mn5TeSXg8n9ikoaAqnTygvgwfRw~6bfa17cf50eb64a553379c2d6eeff50d

Upcoming events on BioCryst Pharmaceuticals, Inc.

2026-08-05	Earnings release - Q2 2026
2026-08-05	Earnings presentation	08:30

Past events on BioCryst Pharmaceuticals, Inc.

2026-06-11	Annual General Meeting	10:00
2026-05-06	Earnings release - Q1 2026
2026-05-06	Earnings presentation	08:30
2026-02-26	Earnings release - Q4 2025
2026-02-26	Earnings presentation	08:30
2025-11-03	Earnings presentation	08:30
2025-11-03	Earnings release - Q3 2025
2025-08-04	Earnings presentation	08:30
2025-08-04	Earnings release - Q2 2025

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	331 328 0.92%	451 449 0.32%	875 620 41.06%	669	726	865
EBITDA Million USD	Released Forecast Spread	-102 -101 -1%	-1,30 18,8 -106.89%	342 96,0 256.65%	-248	193	428
EBIT Million USD	Released Forecast Spread	-104 -83,5 -24.27%	-2,54 12,6 -120.24%	341 121 180.9%	-585	199	249
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-226 -192 -17.8%	-87,0 -73,6 -18.11%	267 30,5 776.13%	-645	151	225
Net income Million USD	Released Forecast Spread	-227 -193 -17.14%	-88,9 -74,7 -19.06%	264 32,1 721.69%	-641	141	194
EPS USD	Released Forecast Spread	-1,18 -1,06 -11.81%	-0,43 -0,35 -21.82%	1,21 0,14 764.29%	-2,58	0,63	0,74
Announcement Date		26/02/24	24/02/25	26/02/26	-

Quarterly results

Fiscal Period	March	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million USD	Released Forecast Spread	117 113 3.92%	132 130 1.14%	146 128 13.89%	163 150 9.03%	159 163 -2.2%	407 151 168.67%	156 151 3.5%	183	166	171	169	191	197	399
EBITDA Million USD	Released Forecast Spread	8,00 -9,00 188.92%	-4,20 9,00 -146.66%	21,6 7,00 207.97%	30,1 22,3 35.17%	29,9 43,0 -30.4%		-701 10,7 -6648.28%	24,6	37,1	40,0
EBIT Million USD	Released Forecast Spread	7,69 6,27 22.64%	-4,51 10,2 -144.36%	21,2 7,26 192.25%	29,8 25,3 17.68%	29,6 30,9 -4.26%	260 23,2 1022.23%	-702 19,3 -3734.68%	45,3	36,2	46,3	39,9	67,0	82,2	85,8
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-13,4 -17,9 24.99%	-26,0 -12,9 -102.17%	0,76 -14,7 105.16%	6,49 5,75 12.8%	12,1 15,1 -19.62%	248 10,5 2266.44%	-721 7,16 -10166.69%	25,4	17,2	29,4	23,4	51,0	66,6	70,7
Net income Million USD	Released Forecast Spread	-14,0 -17,4 19.47%	-26,8 -12,7 -111.05%	0,03 -15,0 100.21%	5,09 3,97 27.94%	12,9 9,48 36.03%	246 11,6 2015.9%	-722 12,1 -6042.05%	31,5	20,4	33,6	20,9	38,6	45,9	49,0
EPS USD	Released Forecast Spread	-0,07 -0,08 11.09%	-0,13 -0,05 -137.49%	0,00 -0,06 -	0,02 0,02 18.34%	0,06 0,05 14.7%	1,12 0,05 2205.95%	-2,98 0,05 -5830.77%	0,12	0,09	0,14	0,11	0,16	0,18	0,19
Announcement Date		04/11/24	24/02/25	05/05/25	04/08/25	03/11/25	26/02/26	06/05/26	-	-	-	-	-	-	-

Upcoming sector events for BioCryst Pharmaceuticals, Inc.

2026-07-27	KURA ONCOLOGY, INC.	Information meeting	08:00
2026-07-28	INVENTIVA	Sales and Revenue Release - Q2 2026	AH
2026-07-29	VIKING THERAPEUTICS, INC.	Earnings release - Q2 2026
2026-07-29	VIKING THERAPEUTICS, INC.	Earnings presentation	16:30
2026-07-29	UNIQURE N.V.	Earnings presentation	08:30
2026-07-29	UNIQURE N.V.	Earnings release - Q2 2026
2026-07-29	OLIX PHARMACEUTICALS, INC	Extraordinary General Meeting	20:30
2026-07-30	MADRIGAL PHARMACEUTICALS, INC.	Earnings presentation	08:00
2026-07-30	MADRIGAL PHARMACEUTICALS, INC.	Earnings release - Q2 2026
2026-07-30	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.	Extraordinary General Meeting	02:30

Past sector events for BioCryst Pharmaceuticals, Inc.

Today	MANNKIND CORPORATION	Information meeting	09:00
2026-07-23	ARGENX SE	Earnings release - Q2 2026
2026-07-23	ARGENX SE	Earnings presentation	08:30
2026-07-23	SUMMIT THERAPEUTICS INC.	Earnings release - Q2 2026
2026-07-23	SUMMIT THERAPEUTICS INC.	Earnings presentation	16:30
Today	SAMSUNG EPIS HOLDINGS CO., LTD.	Earnings release - Q2 2026
2026-07-16	INSMED INCORPORATED	Information meeting	08:00
2026-07-15	AIMED BIO INC.	Extraordinary General Meeting	20:01
2026-07-14	CELCUITY INC.	Information meeting	17:30
2026-07-14	OLIX PHARMACEUTICALS, INC	Présentation aux Actionnaires / Analystes	00:00

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
BCRX Stock
Calendar BioCryst Pharmaceuticals, Inc.

The best tools reserved for subscribers to boost the performance of your investments!